Reviewed by Michael Gill, B. Sc.
25 Osteoarthritis Knee Clinical Trials Near Me
Top Hospitals for Osteoarthritis Knee Clinical Trials
Image of Arizona Research Center in Arizona.
Arizona Research Center
Phoenix
3Active Trials
15All Time Trials for Osteoarthritis Knee
2007First Osteoarthritis Knee Trial
Image of Wake Forest Baptist Health in North Carolina.
Wake Forest Baptist Health
Winston-Salem
3Active Trials
6All Time Trials for Osteoarthritis Knee
2020First Osteoarthritis Knee Trial
Top Cities for Osteoarthritis Knee Clinical Trials
Image of Chicago in Illinois.
Chicago
7Active Trials
Northwestern University Feinberg School of MedicineTop Active Site
Osteoarthritis Knee Clinical Trials by Phase of Trial
Phase 1 Osteoarthritis Knee Clinical Trials
2Active Osteoarthritis Knee Clinical Trials
2Number of Unique Treatments
9Number of Active Locations
FX201Autologous Adipose-Derived Mesenchymal Stromal Cells
Osteoarthritis Knee Clinical Trials by Age Group
18+ Osteoarthritis Knee Clinical Trials
68Active Osteoarthritis Knee Clinical Trials
LY3857210ITIS dietgeniculate artery embolizationSample group 2Moving WellInterventionCannabidiol (CBD)6% aqueous phenol
Most Recent Osteoarthritis Knee Clinical Trials
Top Treatments for Osteoarthritis Knee Clinical Trials
Treatment Name
Active Osteoarthritis Knee Clinical Trials
All Time Trials for Osteoarthritis Knee
First Recorded Osteoarthritis Knee Trial
Oxytocin
3
7
2020
LY3857210
1
1
2022
ITIS diet
1
1
2021
geniculate artery embolization
1
1
2022
Sample group 2
1
1
2023
Recently Completed Studies with FDA Approved Treatments for Osteoarthritis Knee
Treatment
Year
Sponsor
LY356318
2021
Eli Lilly and Company
HP-5000 Topical Patch
2021
Noven Pharmaceuticals, Inc.
XT-150
2020
Xalud Therapeutics, Inc.
TLC599
2019
Taiwan Liposome Company
sc-rAAV2.5IL-1Ra
2019
Mayo Clinic
TLC599
2019
Taiwan Liposome Company

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 31st, 2021

Last Reviewed: November 22nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5. https://pubmed.ncbi.nlm.nih.gov/174038002 Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008 Jan;58(1):26-35. doi: 10.1002/art.23176. https://pubmed.ncbi.nlm.nih.gov/181634973 Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014 Jul;73(7):1323-30. doi: 10.1136/annrheumdis-2013-204763. Epub 2014 Feb 19. https://pubmed.ncbi.nlm.nih.gov/245539084 Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010 Aug;26(3):355-69. doi: 10.1016/j.cger.2010.03.001. Review. Erratum in: Clin Geriatr Med. 2013 May;29(2):ix. https://pubmed.ncbi.nlm.nih.gov/206991595 Freedson PS, Melanson E, Sirard J. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc. 1998 May;30(5):777-81. https://pubmed.ncbi.nlm.nih.gov/95886236 Roos EM, Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. 2003 May 25;1:17. https://pubmed.ncbi.nlm.nih.gov/128014177 Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, Dragomir A, Kalsbeek WD, Luta G, Jordan JM. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008 Sep 15;59(9):1207-13. doi: 10.1002/art.24021. https://pubmed.ncbi.nlm.nih.gov/187593148 Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007 Jul;4(7):28-37. https://pubmed.ncbi.nlm.nih.gov/205264059 Smith PA. Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis: An FDA-Sanctioned, Randomized, Double-blind, Placebo-controlled Clinical Trial. Am J Sports Med. 2016 Apr;44(4):884-91. doi: 10.1177/0363546515624678. Epub 2016 Feb 1. https://pubmed.ncbi.nlm.nih.gov/2683162910 Balestroni G, Bertolotti G. [EuroQol-5D (EQ-5D): an instrument for measuring quality of life]. Monaldi Arch Chest Dis. 2012 Sep;78(3):155-9. Italian. https://pubmed.ncbi.nlm.nih.gov/23614330